Literature DB >> 7120257

Variability of oestrogen and progesterone receptor status between primary breast cancer and nodal metastases: preliminary communication.

D Fernandez, P Sauven, J Alaghband-Zadeh, J I Burn.   

Abstract

The synchronous relationship between oestrogen (ER) and progesterone (PgR) receptor status in primary tumours and their nodal metastases has been analysed in 26 patients. All patients with ER-negative primary tumours were found to have ER-negative axillary nodes but of those with ER-positive tumours only 65% had, correspondingly, all nodes ER-positive. The concentration of ER in the nodes was found to be significantly lower (P less than 0.001) than that in the primary tumour. PgR information was unobtainable in 3 patients. Of the remainder, 75% of those having PgR-negative tumours had all nodes PgR-negative but only 36% of those with PgR-positive tumours had all nodes PgR-positive. PgR levels were found to be generally lower in the axillary nodes but this did not reach statistical significance. The clinical relevance of these findings is discussed.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7120257      PMCID: PMC1438616          DOI: 10.1177/014107688207500909

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   18.000


  9 in total

1.  Oestrogen receptors in breast cancer: a changing concept.

Authors:  G Leclercq; J C Heuson; M C Deboel; W H Mattheiem
Journal:  Br Med J       Date:  1975-01-25

2.  Estrogen receptors and breast cancer response to adrenalectomy.

Authors:  E V Jensen; G E Block; S Smith; K Kyser; E R DeSombre
Journal:  Natl Cancer Inst Monogr       Date:  1971-12

3.  Estrogen receptors in hormone-dependent breast cancers.

Authors:  E V Jensen
Journal:  Cancer Res       Date:  1975-11       Impact factor: 12.701

4.  Estrogen receptor and natural course of breast cancer.

Authors:  A Singhakowinta; H G Potter; T R Buroker; B Samal; S C Brooks; V K Vaitkevicius
Journal:  Ann Surg       Date:  1976-01       Impact factor: 12.969

Review 5.  Current status of estrogen and progesterone receptors in breast cancer.

Authors:  W L McGuire; K B Horwitz; O H Pearson; A Segaloff
Journal:  Cancer       Date:  1977-06       Impact factor: 6.860

6.  Estrogen receptor levels in hormonally progressive mammary tumors.

Authors:  D G Bronn; U Kim; L Divecchia; W E Kibbey; J P Minton
Journal:  J Surg Oncol       Date:  1977       Impact factor: 3.454

7.  The variability of estrogen receptors in metastatic breast cancer.

Authors:  M J Brennan; W L Donegan; D E Appleby
Journal:  Am J Surg       Date:  1979-02       Impact factor: 2.565

8.  Estrogen receptor levels in multiple biopsies from patients with breast cancer.

Authors:  D J Webster; D G Bronn; J P Minton
Journal:  Am J Surg       Date:  1978-09       Impact factor: 2.565

9.  Comparison of estrogen receptor levels in primary and regional metastatic carcinoma of the breast.

Authors:  J L Hoehn; E D Plotka; K B Dickson
Journal:  Ann Surg       Date:  1979-07       Impact factor: 12.969

  9 in total
  4 in total

1.  The relationship between estrogen receptors in primary and secondary breast carcinomas and in sequential primary breast carcinomas.

Authors:  R Hähnel; E Twaddle
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

2.  The inconsistency of molecular subtypes between primary foci and metastatic axillary lymph nodes in Luminal A breast cancer patients among Chinese women, an indication for chemotherapy?

Authors:  Yadong Sun; Xiaofeng Liu; Shude Cui; Lianfang Li; Peiqi Tian; Shanqing Liu; Yong Li; Mengmeng Yin; Chongjian Zhang; Qixin Mao; Jiaxiang Wang
Journal:  Tumour Biol       Date:  2016-01-20

3.  Immunocytochemical study on the variation in estrogen receptors of primary and nodal metastases of breast cancer.

Authors:  M Toi; Y Hamada; Y Seto; M Tanimoto; T Nakamura; T Toge; M Niimoto; T Hattori
Journal:  Jpn J Surg       Date:  1988-03

4.  ERalpha-status of disseminated tumour cells in bone marrow of primary breast cancer patients.

Authors:  Tanja Fehm; Natalia Krawczyk; Erich-Franz Solomayer; Graziella Becker-Pergola; Silke Dürr-Störzer; Hans Neubauer; Harald Seeger; Annette Staebler; Diethelm Wallwiener; Sven Becker
Journal:  Breast Cancer Res       Date:  2008-09-15       Impact factor: 6.466

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.